Cargando…
Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
BACKGROUND: We conducted a phase I trial to determine the safety of systemic chemotherapy prior to abdominopelvic robotic stereotactic ablative radiotherapy (SABR) in women with persistent or recurrent gynecologic cancers. METHODS: Patients were assigned to dose-finding cohorts of day 1 carboplatin...
Autores principales: | Kunos, Charles A., Sherertz, Tracy M., Mislmani, Mazen, Ellis, Rodney J., Lo, Simon S., Waggoner, Steven E., Zanotti, Kristine M., Herrmann, Karin, Debernardo, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456851/ https://www.ncbi.nlm.nih.gov/pubmed/26097831 http://dx.doi.org/10.3389/fonc.2015.00126 |
Ejemplares similares
-
Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
por: Kunos, Charles A.
Publicado: (2016) -
Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies
por: Kunos, Charles A., et al.
Publicado: (2012) -
Stereotactic Radiosurgery for Gynecologic Cancer
por: Kunos, Charles, et al.
Publicado: (2012) -
Stereotactic radiosurgery for brain metastasis from gynecological malignancies
por: Kasper, Ekkehard, et al.
Publicado: (2017) -
Robotic Surgery in Gynecologic Oncology
por: DeBernardo, Robert, et al.
Publicado: (2011)